Evaluation of Rapid stool antigen test for the diagnosis of Helicobacter pylori infection in patients with dyspepsia by Khatun, Salma et al.
Evaluation of Rapid stool antigen test for the diagnosis of     
Helicobacter pylori infection in patients with dyspepsia 
 
Salma Khatun1, Fahmida Rahman1, Khandaker Shadia1, Indrajit Kumar Dutta2, Mohammad 
Nazmul Hoq2, Farjana Akter1, Jalaluddin Ashraful Haq1 
 
1Department of Microbiology, Ibrahim Medical College, Dhaka; 2Department of Gastroenterology, 
Hepatobiliary and Pancreatic Diseases, Bangladesh Institute of Research and Rehabilitation in Diabetes, 
Endocrine and Metabolic Disorders, Dhaka 
 
 
Abstract 
Background and objectives: Several diagnostic assays are used for the detection of Helicobacter pylori 
infection in suspected peptic ulcer cases. H. pylori stool antigen test is a non-invasive method for the 
detection of active infection. The present study has evaluated the efficacy of rapid stool antigen test to 
diagnose H. pylori infection in patients with dyspepsia. 
Materials and methods: Adult patients with complains of dyspepsia attending the Department of 
Gastroenterology, Hepatobiliary and Pancreatic Diseases (GHPD) of BIRDEM hospital for endoscopy 
were included. Gastric biopsy, blood and stool samples were obtained from each participant after 
informed written consent. Rapid urease test (RUT), serum H. pylori immunoglobulin A (IgA) and IgG 
and rapid H. pylori stool antigen (HpSAg) tests were performed. Only stool samples were obtained from 
31 neonates aged 1 to 30 days as negative control for HpSAg test. 
Results: A total of 91 adult patients with complain of dyspepsia were included in the study. Out of 91 
cases, 17 (18.7%) and 74 (81.3%) had peptic ulcer and erosion respectively. HpSAg was positive in 
63.7% cases compared to 42.9% and 62.6% respectively by RUT and IgA. The rate of HpSAg positivity 
was significantly higher (p<0.05) in ulcer compared to erosion cases. HpSAg test was positive in all 
(100%) RUT positive cases. Combination of HpSAg test and IgA yielded highest positive result in both 
ulcer (82.4%) and erosion (84%) cases. H. pylori IgG was positive in all cases. 
Conclusion: The study has demonstrated that HpSAg test is an effective and non-invasive diagnostic tool 
to detect active H. pylori infection in suspected dyspeptic patients. 
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Introduction 
Helicobacter pylori is known to be associated 
with peptic ulcer diseases. More than half of the 
world's population is infected with Helicobacter 
pylori, which is acquired almost always within 
the first 5 years of life [1]. Like other 
developing countries, the prevalence of H. pylori 
is very high in Bangladesh. The reported 
prevalence of H. pylori infection in adults is 
about 90% and more than 80% children become 
infected with H. pylori by the age of 6-9 years 
[2, 3]. Both invasive and non-invasive tests are 
available for the diagnosis of H. pylori infection. 
Invasive tests namely culture, staining, histology 
or rapid urease test (RUT) require biopsy 
specimens during endoscopy while noninvasive 
tests include serology, urea breath test (UBT) 
and stool antigen test (HpSAg). 
Culture of the organism is the gold standard for 
diagnosis of H. pylori infection, but it is not 
available in most laboratories as it requires special 
growth condition and facilities [4]. Histology 
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examination of biopsy material can provide 
important information about morphological 
features indicating severity of gastritis and 
evidence for dysplasia. However, the accuracy of 
histology may be variable due to density of H. 
pylori and sampling error and also subjective to 
experience of the pathologist [5]. Rapid urease test 
(RUT) is simple and provides quick results [6]. It 
is based on urease activity of H. pylori in biopsy 
sample taken during endoscopy. Sensitivity and 
specificity of RUT test depends on number of 
biopsies and bacterial load [7]. Any concomitant 
use of antibiotics reduces bacterial load, and may 
lead to false negative results in RUT, UBT and 
histology [8]. Furthermore, the presence of other 
microorganisms that produce urease can lead to 
false-positive results [9]. Serology is widely used 
for screening patients for H. pylori infection. It has 
a good sensitivity, is quick and relatively 
inexpensive, but has low specificity since antibody 
titers remain high for years after H. pylori 
eradication and have limited value to confirm H. 
pylori active infection [10]. The UBT provides a 
reliable noninvasive method for detection of H. 
pylori infection with sensitivity and specificity of 
88-95% and 95%-100% respectively [7]. But UBT 
involves radio active materials and requires an 
expensive instrument, which is not always 
available in routine clinical laboratories. 
As a gastrointestinal pathogen, H. pylori also 
appear in the stool. Stool tests have the 
advantage of being noninvasive and the specimen 
is easily obtainable. H. pylori stool antigen 
(HpSAg) assay has been proven to be clinically 
useful with sensitivities and specificities of more 
than 90% and is advantageous to confirm 
eradication [8]. It can be used as a routine 
diagnostic tool for H. pylori infection because it 
seems to overcome the limitations of the 
conventional invasive techniques. HpSAg test is 
suitable to use particularly in developing 
countries. Detection of H. pylori antigens in 
fecal sample might be useful for noninvasive 
diagnosis of H. pylori infection in children. 
HpSAg may be useful particularly in selection of 
the cases requiring endoscopic examination, in 
monitoring the response to treatment and in 
epidemiological studies [11]. Therefore, the aim 
of the present study was to evaluate the efficacy 
of a rapid immuno-chromatographic stool 
antigen test to diagnose H. pylori infection in 
dyspeptic patients. 
 
Materials and Methods 
Study population and sample collection: Ninety 
one adult patients with dyspeptic symptoms 
attending the Department of Gastrointestinal, 
Hepatobiliary and Pancreatic Diseases (GHPD) of 
BIRDEM General Hospital for diagnostic 
endoscopy were enrolled in the study. Patients 
treated with any antibiotics, colloidal bismuth 
compounds, proton pump inhibitors (PPI) or H2 
blocker within the last four weeks were excluded 
from the study. Gastric biopsy specimen was 
obtained during endoscopy from every adult 
patient for detection of H. pylori infection by 
rapid urease test (RUT). In addition, stool (20-30 
gm) and blood (2.5 ml) samples were collected 
from each patient. Stool samples were tested for 
H. pylori antigen within 6 hours of collection. 
Blood was collected for the detection of H. pylori 
IgG and IgA antibodies. Thirty one neonates aged 
1 to 30 days who were admitted in Special Care 
Baby Unit (SCABU) of BIRDEM Hospital were 
included in the study as healthy control. Only 
stool samples were collected from the neonates 
for the detection of fecal H. pylori antigen. 
The study was approved by the Institutional 
Review Board and written informed consent was 
obtained from all cases. Consent was obtained 
from the guardians of the neonates for collection 
of fecal samples. All laboratory works were 
carried out in the Department of Microbiology, 
Ibrahim Medical College, Dhaka. The study 
period was from July 2012 to February 2014. 
Sample preparation: After collection, blood was 
kept at room temperature for at least half an 
hour followed by centrifugation at 1500 rpm for 
10 minutes. Then the serum was separated and 
stored at –200C. Later on the serum was used for 
detection of anti H. pylori antibodies. For stool 
antigen assay, the cap of the specimen collection 
tube was unscrewed and then the specimen 
collection applicator was stabbed randomly into 
fecal specimen in at least 3 different sites to 
collect approximately 50 mg of feces. The 
applicator was inserted back into the tube and 
then the cap was tightened. Collection tube was 
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shaken vigorously using vortex mixer and then 
centrifuged for 5 minutes at 4000 rpm. The 
supernatant was used for the assay. 
Rapid urease test (RUT): Immediately after 
collection, the biopsy specimen was suspended 
in the rapid urease test media. Then the medium 
was incubated at 370C and examined after 4 
hours or after over-night incubation (24 hrs) to 
detect urease activity. The test was considered 
positive if the colour of the medium changed 
from yellow to pink [12, 13]. 
H. pylori stool antigen assay: Stool samples were 
analyzed for H. pylori antigen using ABON one 
step H. pylori antigen test device (Inverness 
Medical Innovation Hong Kong Limited). It is a 
lateral flow chromatographic immunoassay. The 
test was performed as per instruction of the 
manufacturer. Two drops of extracted stool sample 
was added to the sample well of the test kit. The 
result was read 10 minutes after dispensing the 
sample. A test was considered positive when a 
purple-pink line (test line) appeared in addition to 
the control line and was considered negative when 
only the control line appeared. Lack of control line 
indicated invalid result. 
H. pylori IgG and IgA detection by ELISA: 
Serum samples were tested for the presence of 
anti H. pylori IgG and IgA antibodies. Test was 
performed by DRG H. pylori IgG and IgA 
ELISA kit (DRG International Inc., USA) 
according to manufacturer’s instruction. 
Results 
Present study was carried out on 91 adult 
dyspeptic patients and 31 neonates (aged 1– to 
30 days). Of 91 patients, 17 (18.7%) were 
diagnosed as peptic ulcer and 74 (81.3%) as 
erosion by endoscopy. HpSAg showed higher 
positivity (76.5%) in ulcer cases. Overall 
positivity of HpSAg was higher (63.7%) in 
comparison to RUT (42.9%) and IgA (62.6%) 
except IgG (97.8%). Out of 91, cases, 83.5% 
was positive for either HpSAg or IgA (Table1). 
HpSAg test was compared with RUT and 
serology. Out of 58 HpSAg positive cases, 
67.2% were positive by RUT (Table 2). None of 
the HpSAg negative case was positive by RUT. 
HpSAg positive cases show higher IgA and IgG 
positivity than stool Ag negative cases. IgG was 
positive in all HpSAg positive cases. RUT and 
serology were compared with HpSAg test alone 
and in combination (Table 3). All the 39 RUT 
positive cases were also positive by HpSAg test 
(100%). Out of 52 RUT negative cases, 19 
(36.53%) were stool antigen positive. All the 26 
RUT and IgA positive cases were also positive 
for HpSAg. We included fecal samples from 31 
neonate aged 1 to 30 days as a negative control 
for stool antigen. It was considered that the 
neonates would not be exposed to H. pylori. 
Among them, 1 (3.23%) was positive for stool 
antigen. The HpSAg method had a sensitivity of 
100% for detection of H. pylori infection. 
 
Table-1: Results of RUT, serum H. pylori IgG, IgA and HpSAg tests for detection of H. pylori infection 
in study population 
 
 
Diagnosis 
Total 
No. of 
case 
Number (%) positive by 
RUT HpSAga IgA IgG 
HpSAg/ 
IgA 
HpSAg/
RUT 
HpSAg/ 
IgG 
Ulcer 17 10  
(58.8) 
13 
 (76.5) 
12  
(70.5) 
17 
 (100) 
14 (82.4) 13 (76.5) 17 (100) 
Erosion 74 29 
 (39.1) 
45 
 (60.8) 
45  
(60.8) 
72  
(97.2) 
62 (84.0) 45 (61.0) 72 (97.2) 
 
Total 91 39  
(42.9) 
58  
(63.7) 
57  
(62.6) 
89  
(97.8) 
76 (83.5) 58 (63.7) 89 (97.8) 
 
 
Note: HpSAg/IgA indicate either HpSAg or IgA positive; HpSAg/RUT indicate either HpSAg or RUT positive; a= 
p<0.05), compared between ulcer and erosion cases for HpSAg test; p< 0.05, compared between HpSAg and 
RUT. For HpSAg 95% CI: 53.8%-73.6%. For HpSAg/IgA 95% CI: 75.8%-91.1% 
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Table-2: Relation of H. pylori stool antigen 
(HpSAg) detection with RUT and H. pylori 
antibodies in ulcer and erosion patients (n=91) 
 
Test 
No. 
of 
cases 
Number (%) positive by 
RUT IgA IgG 
Both 
IgA+IgG 
HpSAg 
Positive  
58 39 
(67.2) 
38 
(65.5) 
58 
(100) 
39 
(67.2) 
HpSAg 
Negative 
33 0 19 
(57.5) 
31 
(96.8) 
17 
(51.5) 
 
 
Table-3: Comparison of RUT, serum H. pylori IgG 
and IgA with HpSAg test  
 
Test 
Test 
result 
No of 
Cases 
Positive for 
HpSAg 
N (%) 
RUT 
 
Positive 
Negative 
39 
52 
39 (100) 
19 (36.5) 
IgA 
 
Positive 
Negative 
57 
34 
38 (66.7) 
20 (58.8) 
IgG 
 
Positive 
Negative 
89 
2 
58 (65.1) 
0 
RUT+IgA 
 
Positive 
Negative 
26 
21 
26 (100) 
7 (33.3) 
RUT+IgG 
 
Positive 
Negative 
39 
2 
39 (100) 
0 
 
 
Discussion 
Accurate diagnosis of H. pylori infection is 
essential for the effective treatment and 
management of infection caused by H. pylori. 
Numerous invasive and noninvasive diagnostic 
tests have been developed. Each of the techniques 
has advantages as well as disadvantages depending 
on the clinical situation. In the present study, rapid 
immuno-chromatographic H. pylori stool antigen 
test was evaluated and compared with RUT and 
serology. It has been observed that the rate of 
positivity of RUT, HpSAg and serological tests 
were comparatively less in erosion compared to 
ulcer cases. However, when either HpSAg or IgA 
were considered then the rate of positivity in both 
ulcer and erosion cases were almost same (82.4% 
and 84%). Therefore, the sensitivity of the 
diagnosis increases if two tests are employed 
together.  
All our RUT positive cases were also positive by 
HpSAg test. So it reveals that HpSAg test can 
efficiently detect H. pylori infection. This result 
matches with the findings of a similar study 
conducted in Kuwait University, where 52% of the 
patients had a positive RUT test when they used a 
single antral biopsy as we did [13]. Furthermore 
among RUT negative cases, 36.53% were HpSAg 
positive. This may be due to the fact that in the 
RUT, false-negative results may occur because of 
irregular distribution of bacteria in the gastric 
mucosa [14]. Several biopsy specimens are 
necessary for more accurate result. 
It is apparent from the study that the rapid one step 
HpSAg assay has produced promising results for 
the detection of H. pylori antigen in stool samples. 
The result is comparable to another study where 
they found 66.7% of patients were positive for 
H. pylori stool antigens [15]. Almost all cases in 
our study were found IgG positive (97.8%) though 
many of them were negative for RUT, HpSAg and 
IgA. Probably, IgG was positive in those cases due 
to past infection or subclinical exposure to H. 
pylori. In contrast to serum IgG, the IgA titers rise 
rapidly after infection and decrease if the infection 
is cleared [2, 3].  
In the present study both IgA and IgG antibodies 
were positive in 67.2% HpSAg positive cases. 
These cases were considered as true infection. On 
the other hand, 51% of HpSAg negative case were 
positive for both antibodies (Table 3). These cases 
should be very carefully diagnosed by other 
methods. It also appears in this study that positivity 
rate of IgA antibody (62.6%) and HpSAg (63.7%) 
is almost equal which is much higher than RUT 
(42.9%). A comparison of HpSAg with RUT and 
serum IgA test was made for evaluating 
competence of HpSAg in detecting H. pylori 
infection in our study population. Serum IgG could 
not be considered as a diagnostic marker of active 
H. pylori infection as almost all cases were positive 
for IgG. On the other hand, IgA antibody could be 
specific for active infection with H. pylori [16]. In 
our study, both RUT and IgA positive 26 cases 
were also positive by HpSAg. So it reveals that 
HpSAg assay can efficiently detect active H. pylori 
infection. Furthermore, 33.3% cases were also 
positive for HpSAg among 21 both RUT & IgA 
negative cases. 
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Though culture is usually considered as gold 
standard to determine H. pylori infection, it is not 
performed in this study because of some 
limitations. Therefore, to determine specificity of 
the HpSAg test, stool samples were collected from 
31 neonates. These neonates were considered as 
‘disease negative’ because their possibility to 
infection by H. pylori was almost nil. However, 
out of 31 neonates stool samples, one (3.23%) 
neonate was positive for H. pylori stool antigen 
test. Another study with infants found 5 out of 172 
newborns (2.9%) positive for H. pylori by stool 
antigen test at the 1st month of age [17]. The 
sensitivity of HpSAg test was thus 100% in our 
study. A systematic review of stool antigen test in 
untreated H. pylori infected patients reported 
sensitivity of 91%, specificity of 93%, and positive 
and negative predictive values of 92% and 87%, 
respectively [18].  
The rapid noninvasive immune-chromatographic 
HpSAg test is a quick and cost effective method to 
detect active H. pylori infection. It does not require 
specialized expertise and expensive laboratory 
facilities. In conclusion, the study has showed that 
HpSAg test can be a reliable alternative to other 
techniques for diagnosing active H. pylori infection 
in non treated patients with dyspepsia. It may be 
considered as a noninvasive first-line test for 
diagnosis of H. pylori infection in our region 
especially for children. The test may further be 
used in monitoring the therapeutic response in H. 
pylori infection. 
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